⌘K

Home/Filings/4/0001683168-25-009114

4//SEC Filing

Silverman Joshua 4

Accession 0001683168-25-009114

CIK 0001157075other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 5:07 PM ET

Size

7.3 KB

Accession

0001683168-25-009114

Insider Transaction Report

Form 4

Period: 2025-12-12

PharmaCyte Biotech, Inc.PMCB

Silverman Joshua

DirectorCEO and President

Transactions

Award
Common Stock
2025-12-12+575,000→ 575,000 total
Tax Payment
Common Stock
2025-12-12$1.02/sh−258,750$263,925→ 316,250 total

Holdings

Common Stock
(indirect: By LLC)
50,000

Footnotes (1)

[F1]Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction.

Documents

1 file

4
ownership.xmlPrimary

Issuer

PharmaCyte Biotech, Inc.

CIK 0001157075

Entity typeother

Related Parties

1

filerCIK 0001524858

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 5:07 PM ET
Size: 7.3 KB

View on SEC.gov